Abstract:Objective To evaluate the relevance of molecular alterations and histopathological subtypes of lung adenocarcinoma according to 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification. Methods Mutations of epidermal growth factor receptor (EGFR) 18-21 exons ( E18-21 ),KRAS 12/13 codons and EML4-ALK fusion in 212 cases of lung adenocarcinoma which underwent complete tumor resection,were detected by immunohistochemistry,PCR-amplifying and gene sequencing.The relevance of the molecular alterations to histopathological subtypes based on the new classification and 2004 WHO classification were further characterized. Results Mutations of EGFR were observed in 49.6％ of lung adenocarcinomas,involving mainly E21 (52.4％,55/105 ) and E19 ( 36.2％,38/105). Mutations of KRAS were detected in 8％ cases of adenocarcinoma,involving mainly codon 12 (15/17). EML4-ALK fusions were found in 6.1％ of lung adenocarcinoma,the most common fusion mutation was type V1 ( E13; A20) (7/13),followed by type V3a/b ( E6a/b; A20) (4/13).Based on the new classification, 7/10 lepidic, 63.2％ (48/76) papillary, and 5/8 micropapillary predominant adenocarcinomas harbored EGFR mutations. EGFR mutations showed significant difference among different histological subtypes (P =0.008). KRAS mutations were most frequently found in invasive mucinous adenocarcinoma (1/2),followed by colloid predominant adenocarcinoma (3/7). There was siguificant difference of KRAS mutations among different histological subtypes ( P =0.003 ).EMLA-ALK fusions were most frequently found in the solid predominant with mucin production subtype ( 15.4％,6/39),followed by colloid predominant adenocarcinoma ( 1/7 ),and no significant difference of EMLA-ALK fusions was found among different histological subtypes ( P =0.181 ). Significant TTF-1 overexpression was observed in adenocarcinomas harbored EGFR mutations (P =0.008 ),and no or significantly lower level expression of TTF-1 was observed in adenocarcinomas harbored KRAS mutations (P =0.000). However,there was no association between TTF-1 expression and EML4-ALK fusions ( P =0.274 ). Based on the 2004 WHO classification,mutations of KRAS ( P =0.002 ) and EML4-ALK (P =0.000),rather than EGFR ( P =0.502),showed significant differences among different subtypes. According to both classification systems,the difference of " triple negative" adenocarcinomas was not significant among different subtypes ( P =0.684,P =0.449, respectively ). Conclusions The new classification, combined with TTF-1 immunomarker,can help to predict the molecular alterations of EGFR and KRAS genes,but can not indicate the EML4-ALK fusion in lung adenocarcinoma. Lepidic, papillary, and micropapillary predominant adenocarcinomas with TTF-1 expression are closely related to the presence of EGFR mutation,and invasive mucinous adenocarcinoma,while colloid predominant adenocarcinoma without TTF-1 expression is closely related to the presence of KRAS mutation.

The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort

Comprehensive Investigation of Mutational Features of Various Lung Adenocarcinoma Histological Subtypes among Chinese Patients.

Oncogenic Mutations Are Associated with Histological Subtypes but Do Not Have an Independent Prognostic Value in Lung Adenocarcinoma

The IASLC Grading System for Invasive Pulmonary Adenocarcinoma: a Potential Prognosticator for Patients Receiving Neoadjuvant Therapy

Clinical value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma (vol 8, pg 159, 2017)

Prognostic Significance of the IASLC/ATS/ERS Classification in Chinese Patients—a Single Institution Retrospective Study of 292 Lung Adenocarcinoma

Correlation of Survival and EGFR Mutation with Predominant Histologic Subtype According to the New Lung Adenocarcinoma Classification in Stage IB Patients

Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients

Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study

Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification

Risk Stratification Model for Patients with Stage I Invasive Lung Adenocarcinoma Based on Clinical and Pathological Predictors.

A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

Histopathologic Pattern and Molecular Risk Stratification Are Associated with Prognosis in Patients with Stage IB Lung Adenocarcinoma

The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma

Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value

[Analysis of the Effect of Different Pathological Subtypes to Prognosis in Stage I Pulmonary Adenocarcinoma].

The Histologic Classifications of Lung Adenocarcinomas Are Discriminable by Unique Lineage Backgrounds.

The prognostic value of histopathology in invasive lung adenocarcinoma: a comparative review of the main proposed grading systems

P3.02-028 276 Cases of EGFR/ALK Gene Status and Predominant Histologic Subtype in Chinese Surgically Resected Lung Adenocarcinoma

Reevaluation of Survival and Prognostic Factors in Pathologic Stage I Lung Adenocarcinoma by the New 2009 TNM Classification

Clinicopathologic study based on 2 056 cases of pulmonary resection of lung adenocarcinoma